Inventor · disambiguated record
Hong Sun
Also filed as: SUN HONG · Sun hong-bin
6 granted patents·11 pending applications·21 citations·filing 2014–2024
77Inventor score
Files withAMGEN INC5DENOVO BIOPHARMA LLC5JIANGSU VCARE PHARMATECH CO LTD3ARISSA PHARMA LTD1JANSSEN BIOTECH INC1
Top patents by PatentIndex Score
17 records- 0191US10822408B2PACAP antibodies and uses thereofAMGEN INC·Filed 2016·Granted Nov 3, 2020·10 cites·23 claims
- 0290US10259877B2Methods for treating or preventing migraine headacheAMGEN INC·Filed 2016·Granted Apr 16, 2019·8 cites·58 claims
- 0386US11466090B2Methods for treating or preventing migraine headacheAMGEN INC·Filed 2019·Granted Oct 11, 2022·3 cites·38 claims
- 0470US2023020514A1Methods for treating or preventing migraine headacheAMGEN INC·Filed 2022·Application pending·0 cites
- 0567US2023074781A1Methods and composition for the prediction of the activity of enzastaurinDENOVO BIOPHARMA LLC·Filed 2022·Application pending·0 cites
- 0665US2015011583A1Optically active 2-hydroxy tetrahydrothienopyridine derivatives, preparation method and use in manufacture of medicament thereofJIANGSU VCARE PHARMATECH CO LTD·Filed 2014·Application pending·0 cites
- 0764US2024417801A1Compositions and methods for assessing the efficacy of polynucleotide delivery and cancer therapyDENOVO BIOPHARMA LLC·Filed 2024·Application pending·0 cites
- 0863US11780914B2PACAP antibodies and uses thereofAMGEN INC·Filed 2020·Granted Oct 10, 2023·0 cites·19 claims
- 0958US10000506B2Optically active 2-hydroxy tetrahydrothienopyridine derivatives, preparation method and use in manufacture of medicament thereofJIANGSU VCARE PHARMATECH CO LTD·Filed 2016·Granted Jun 19, 2018·0 cites·9 claims
- 1058US2024024477A1T cell receptors and uses thereofUNIV OXFORD INNOVATION LTD·Filed 2021·Application pending·0 cites
- 1154US2019055260A1Optically active 2-hydroxy tetrahydrothienopyridine derivatives, preparation method and use in manufacture of medicament thereofJIANGSU VCARE PHARMATECH CO LTD·Filed 2018·Application pending·0 cites
- 1253US2023193388A1Compositions and methods for assessing the efficacy of inhibitors of neurotranmitter transportersDENOVO BIOPHARMA LLC·Filed 2021·Application pending·0 cites
- 1351US2022193062A1Combination of enzastaurin and inhibitors of btk and uses thereofDENOVO BIOPHARMA LLC·Filed 2019·Application pending·0 cites
- 1450US11421280B2Methods and composition for the prediction of the activity of enzastaurinDENOVO BIOPHARMA LLC·Filed 2017·Granted Aug 23, 2022·0 cites·20 claims
- 1550US2022144946A1Fcrn antibodies and methods of use thereofJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 1643US2022395514A1Low-dose celecoxib preparationARISSA PHARMA LTD·Filed 2019·Application pending·0 cites
- 1739US2017216305A1Compositions comprising meloxicam-cyclodextrin inclusion complexes and methods of treating acute painSUN HONG·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →